Tirzepatide/TR/Fitness and Weight Loss/99% high-purity/on-time shipment/ reasonable price/fast and safe delivery/available in stock in the warehouse
TDS 35 Inquiries
129954-34-3
Cosmetics Grade
99.9%
XiangGang
DS
5mg*10vials 10mg*10vials 40mg*10vials
2026-08-07 ~ 2026-08-31
Medical and health products,Peptide products
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionSELANK Synthetic is a single, non-glycosylated polypeptide chain containing 7 amino acids, having a molecular mass of 751.89 Dalton and a Molecular formula of C33H57N11O9.CertificatesBasic Info
-
Product Name:
Selank peptide
Other Name:Selank peptide;SelankAcetate;PL14736;L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-L-proline;L-THREONYL-L-LYSYL-L-PROLYL-L-ARGINYL-L-PROLYLGLYCYL-L-PROLINE; MONOACETATE;H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH;SLANK;Selank peptid
CAS No.:129954-34-3
Molecular Formula:C33H57N11O9
InChIKeys:JTDTXGMXNXBGBZ-YVHUGQOKSA-N
Molecular Weight:751.87
Exact Mass:751.43407244
EC Number:232-660-2
UNII:TS9JR8EP1G
Categories:
Characteristics-
Density:
1.53±0.1 g/cm3(Predicted)
Melting Point:134-136 °C
PKA:3.43±0.20(Predicted)
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medical and health products,Peptide products
-
Location:
Room 210, 2nd Floor, Office Building No.1, Dezhou Fushite Electric Motor Co., Ltd., North of Xiaoli Road and West of Tianlong Village, Tianqu Sub-district Office
-
Payment Terms:
100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
Certifications:
COA,COA
-
-
Inquiry History35 Inquiries
Country Product Purchase Quantity Date Posted
United States
Selank 99% Purity 129954-34-3
1 G Jan 23, 2026
Greece
selank
10 MG May 20, 2026
United States
N acetyl selank
500 MG Apr 30, 2026
United States
Selank
100 MG Apr 24, 2026
Italy
Nacetyl selank
1 MT Apr 22, 2026
Oman
Selank
1 G Mar 4, 2026
United States
Selank
30 40' Fcl Oct 14, 2025
United States
selank
30 MG May 25, 2026
Brazil
Selank
10 MT Apr 7, 2026
United States
selank
1 G Mar 13, 2026
United States
Selank
1 G Mar 9, 2026
United Kingdom
Selank
1 G Dec 22, 2025
United States
Selank
20 MG Nov 10, 2025
United States
NA-Selank Amidate
10 MG Sep 18, 2025
United Kingdom
Selank
100 MG Jul 15, 2025
United States
N-Acetyl Selank Amidate
1 KG Jan 9, 2025
United States
Selank
10 Mar 29, 2024
Poland
Selank
10 G Feb 18, 2024
United States
Selank
1 G Jan 27, 2024
United States
selank
100 MG Jul 7, 2026 Post an enquiry for this product
